Blood Test Identifies AML Patients at Risk of Posttransplant Relapse
National Institutes of Health
A small portion of acute myeloid leukemia patients in remission showed persisting mutations, which predicted their risk of death from cancer relapse
Further research can alter the prognosis and improve quality of life in patients with leukemia